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basal diet + 0.056% β-mannanase), or the immune system stimulation treatment (ISS; basal diet + 0.056% 
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every 48 h beginning on d 10. Blood was collected pre- and post-challenge for complete blood counts 
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Lipopolysaccharide immune stimulation
but not β-mannanase supplementation
affects maintenance energy requirements
in young weaned pigs
Nichole F. Huntley1, C. Martin Nyachoti2 and John F. Patience1*
Abstract
Background: Pathogen or diet-induced immune activation can partition energy and nutrients away from growth,
but clear relationships between immune responses and the direction and magnitude of energy partitioning
responses have yet to be elucidated. The objectives were to determine how β-mannanase supplementation
and lipopolysaccharide (LPS) immune stimulation affect maintenance energy requirements (MEm) and to
characterize immune parameters, digestibility, growth performance, and energy balance.
Methods: In a randomized complete block design, 30 young weaned pigs were assigned to either the control treatment
(CON; basal corn, soybean meal and soybean hulls diet), the enzyme treatment (ENZ; basal diet + 0.056% β-mannanase),
or the immune system stimulation treatment (ISS; basal diet + 0.056% β-mannanase, challenged with repeated increasing
doses of Escherichia coli LPS). The experiment consisted of a 10-d adaptation period, 5-d digestibility and nitrogen balance
measurement, 22 h of heat production (HP) measurements, and 12 h of fasting HP measurements in indirect calorimetry
chambers. The immune challenge consisted of 4 injections of either LPS (ISS) or sterile saline (CON and ENZ), one every
48 h beginning on d 10. Blood was collected pre- and post-challenge for complete blood counts with differential,
haptoglobin and mannan binding lectin, 12 cytokines, and glucose and insulin concentrations.
Results: Beta-mannanase supplementation did not affect immune status, nutrient digestibility, growth performance,
energy balance, or MEm. The ISS treatment induced fever, elevated proinflammatory cytokines and decreased leukocyte
concentrations (P < 0.05). The ISS treatment did not impact nitrogen balance or nutrient digestibility (P > 0.10),
but increased total HP (21%) and MEm (23%), resulting in decreased lipid deposition (−30%) and average daily
gain (−18%) (P < 0.05).
Conclusions: This experiment provides novel data on β-mannanase supplementation effects on immune
parameters and energy balance in pigs and is the first to directly relate decreased ADG to increased MEm
independent of changes in feed intake in immune challenged pigs. Immune stimulation increased energy
partitioning to the immune system by 23% which limited lipid deposition and weight gain. Understanding
energy and nutrient partitioning in immune-stressed pigs may provide insight into more effective feeding
and management strategies.
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Background
The negative influence of an immune challenge on ani-
mal growth is well established. Pro-inflammatory cyto-
kines orchestrate an immune response resulting in fever,
acute phase protein (APP) production, and leukocyte
proliferation, each of which requires additional energy
and amino acids (AA). Therefore, a perceived immune
challenge can theoretically partition energy and nutri-
ents away from productive processes such as muscle
growth and negatively impact the efficiency and cost of
meat production [1]. Innate immune activation occurs
when pathogen-associated molecular patterns are de-
tected such as the lipid-A component of lipopolysac-
charide (LPS) from gram-negative bacteria [2]. However,
certain dietary components, such as β-mannan in soy-
bean, copra, and palm kernel meals, mimic carbohydrate
structures on pathogen surfaces [3] and have previously
been shown to activate the innate immune system [4, 5],
termed a feed-induced immune response (FIIR).
To inhibit a β-mannan derived FIIR, interest in
β-mannanase enzyme supplementation has increased. It is
hypothesized that the hydrolyzed manno-oligosaccharides
can no longer crosslink and stimulate multiple mannose
receptors, thus reducing immune stimulation and associ-
ated energy costs. Research in poultry demonstrated that
β-mannanase decreased plasma APP concentration and
improved growth performance and feed efficiency leading
to the conclusion that β-mannanase supplementation
spared energy through prevention of the FIIR [6, 7]. In
pigs, performance responses to β-mannanase are less con-
sistent than in poultry and reports on immune responses
are limited and effects on energy partitioning have yet to
be evaluated.
Nutrient partitioning in pigs during a pathogen
challenge has received more attention, often utilizing a
LPS challenge model [8]. Physiological responses to a
LPS challenge in pigs have been well characterized. Simi-
lar to disease challenges, LPS induces anorexia, fever,
and nutrient repartitioning leading to decreased growth
and efficiency [1, 2, 9]. Fever is an energetically expen-
sive process and its effects on sheep and human main-
tenance energy requirements have been estimated [10].
Immune system activation also significantly shifts glu-
cose metabolism and glucose requirements during an
LPS challenge in pigs have been estimated to be approxi-
mately 1.1 g/(kg BW0.75·h) [11]. Yet few studies have
addressed comprehensive changes in energy partitioning
during an immune response and clear relationships
between measured immune responses and the direction
and magnitude of changes in energy partitioning have
yet to be elucidated.
Therefore, the objectives of this experiment were to
determine how β-mannanase supplementation and in-
nate immune stimulation each affect maintenance
energy requirements and to characterize changes in
immune parameters, nutrient digestibility, growth
performance, and energy balance. We hypothesized that
innate immune stimulation would increase maintenance
energy requirements by initiating a cytokine-driven
febrile response and inflammatory state, and that
β-mannanase supplementation would decrease mainten-
ance energy requirements through an energy sparing
effect of FIIR prevention.
Methods
All experimental procedures adhered to guidelines for
the ethical and humane use of animals for research and
were reviewed and approved by the University of
Manitoba Animal Care Committee.
Animals and experimental design
Thirty growing barrows [(Yorkshire × Landrace) ×
Duroc] were acquired from the Glenlea Swine Research
Unit, University of Manitoba at an average body weight
(BW) of 9.60 ± 2.00 kg. The experiment was conducted
using a randomized complete block design. Pigs were
blocked by weight and randomly assigned to one of
three treatments (Table 1). A staggered time course was
utilized to accommodate the limited number of calorim-
etry chambers available, whereby 10 blocks of three pigs
each (one pig per treatment) began the experiment 4 d
after the previous block. Day one BW was similar among
treatments (10.27 ± 0.08 kg).
Experimental diets, treatments and procedures
All diets were formulated on the ratio of standardized
ileal digestible lysine to metabolizable energy (ME) and
met or exceeded all specified nutrient requirements of
growing pigs from 11 to 25 kg [12]. Pigs were fed at 2.5
times their maintenance ME requirements [12], once
daily at 08:00 h and had free access to water at all times.
Pigs were fed a common pre-trial diet (Additional file 1:
Table S1) that was corn-soybean meal-based. The ex-
perimental basal diet (Table 2) was formulated with high
soybean meal and soybean hull inclusion levels to in-
crease dietary β-mannan concentration.
Due to the availability of three indirect calorimetry
chambers, three experimental treatments were evaluated
(Table 1). The control treatment (CON) received the
basal diet, while the enzyme treatment (ENZ) received
CON supplemented with 0.056% β-mannanase (Hemi-
cell™ HT-D, Elanco Animal Health, Guelph, ON, Canada;
endo-1,4-β-mannanase (160 × 106 units/kg) from Paeni-
bacillus alvei). The third treatment was challenged with
repeated LPS immune system stimulation (ISS) and re-
ceived the same diet as ENZ. This treatment design was
determined based on the hypothesis, supported by previ-
ous research, that β-mannanase would inhibit a FIIR if it
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occurred in CON [6, 7]. In this way, the effect of an in-
nate immune stimulation by LPS could be evaluated in-
dependent of a FIIR.
Upon arrival and during the pre-trial period, pigs
were housed individually in pens (1.83 m × 1.22 m) with
plastic-covered expanded metal flooring in a
temperature-controlled room (26 ± 2 °C). Daily feed
allotment during the pre-trial period was adjusted
based on BW measured every 4 d. Pigs were maintained
on the pre-trial diet for at least 4 d until initiation of
the experiment for their respective block, at which time
pigs received their assigned treatment diets. The ex-
periment consisted of a 10-d adaptation phase, a 5-d
total feces and urine collection phase, and 34 h of heat
production (HP) measurements.
At trial initiation (d 1), pigs were individually housed
in adjustable metabolism crates (1.80 m × 0.60 m) with
smooth transparent plastic sides and plastic-covered ex-
panded metal flooring in a temperature controlled room
(26 ± 2 °C). Body weight was measured on d 1, 5, 10, 16,
daily feed allotment was adjusted accordingly, and pigs
were trained to consume the entire meal within 1 h of
feeding at 08:00 h. Orts, if any, were measured to accur-
ately determine average daily feed intake (ADFI).
Immune challenge
A low dose, repeated LPS challenge, following the modi-
fied procedures described by Rakhshandeh and de Lange
[8], was chosen to induce an inflammatory response
representative of sustained immune system stimulation
in the ISS treatment. The challenge consisted of four
repeated low-dose injections of Escherichia coli LPS
serotype O55:B5 (Sigma–Aldrich, St. Louis, MO, USA)
for pigs on treatment ISS, or a control injection of sterile
saline for pigs in treatments CON and ENZ. The LPS
was dissolved in sterile PBS so that an injection of
0.1 mL/kg of BW achieved the desired dosage [13].
A pilot study with 12 pigs was conducted prior to ex-
periment initiation to discern the lowest appropriate ini-
tial LPS dose and the subsequent dose increase regimen
required to limit LPS tolerance development. Results of
the pilot study (not reported herein) indicated that an
initial dose of 20 μg LPS/kg of BW with subsequent dose
increases of 20%, 30%, and 40% was the regimen that
maintained a febrile response (rectal temperature ≥
40 °C) at all four challenges while minimizing an-
orexia and vomiting.
During the main experiment, pigs were injected intra-
muscularly at 10:00 h on d 10, 12, 14, and 16 with either
sterile saline or LPS, following the previously described
dosing regimen determined from the pilot study. Baseline
rectal temperature was measured on d 5 and 8 at 14:00 h
and at 4 h post-challenge (14:00 h) on d 10, 12, and 14.
Blood samples were then collected on d 8 (pre-challenge)
and d 10 (post-challenge) via jugular venipuncture into
two 10-mL tubes for EDTA-whole blood and serum.
Whole blood samples were placed on ice pending trans-
portation to the laboratory for complete blood count
(CBC) analysis with white blood cell (WBC) manual dif-
ferential. Serum was separated by centrifugation (2,000×g
for 15 min at 4 °C), collected and divided into three sub-
samples, and stored at − 80 °C until analyzed.
Digestibility
On d 10, pigs received 5 g of ferric oxide as an indigest-
ible marker mixed with 100 g of feed; the remaining
allotted feed was offered after the marked feed was con-
sumed. Fecal collection commenced when the marker
first appeared in the feces. On d 15, pigs were offered
100 g of marked feed as previously described, and fecal
collection terminated when the marker appeared in the
feces. Feces were weighed and stored at − 20 °C until fur-
ther processing. Total urine collection commenced at
08:00 h on d 11 and terminated at 08:00 h on d 16. Urine
was collected once daily into jugs containing 10 mL of
6 mol/L HCl. Urine was weighed, thoroughly mixed and
subsampled (10% of urine weight), strained through glass
wool, and stored at − 20 °C. Urine subsamples were
pooled per pig throughout the collection period.
Heat production
On d 16, within 30 min of consuming their daily feed al-
lotment, pigs were transferred to open-circuit indirect
calorimetry chambers (1.22 m × 0.61 m × 0.91 m metallic
box with a glass door on the front side, plastic-covered
expanded metal sheet flooring, and a valve at the bottom
to collect urine; Columbus Instruments, Columbus, OH,
USA) for 34 h of calorimetric measurements. Pigs were
Table 1 Summary of experimental treatments
Experimental treatment
CONa ENZb ISSc
Diet Control Control + β-Mannanase Control + β-Mannanase
β-mannanase inclusion No Yes Yes
Challenge treatment Saline Saline E. coli LPS
aControl treatment (CON) = pigs fed basal diet with no LPS (Escherichia coli serotype O55:B5) injection
bEnzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with no LPS injection
cImmune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with LPS injection
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randomly assigned to chambers to reduce the possibility
of a chamber bias. The first 2 h of HP (08:00–10:00 h),
measured prior to pigs receiving the fourth and final
challenge of either LPS or saline, were designated as ac-
climation and not included in HP calculations. Total
oxygen consumption (VO2) and carbon dioxide produc-
tion (VCO2) were measured every 12 min corresponding
to 170 values over 34 h. The first 24 h following feeding
was designated as the fed state and the last 12 h as the
fasting state [14, 15]. Urine voided during the fed and
fasting periods was collected separately and processed as
previously described. Personnel movement within the
room was minimized during HP measurement to avoid
any disturbance of the pigs. The system was validated
using the alcohol combustion method described by
Aulick et al. [16] and the O2 and CO2 sensors were
calibrated prior to each block of the experiment. The
chambers were air-conditioned to maintain a constant
temperature (23 ± 1 °C). Pig BW on d 16 was similar
across all treatments (14.1 ± 0.3 kg). Heat production
was measured in only seven of the ten experimental
blocks because of equipment failure during three blocks;
therefore, for HP data, n = 7.
Analytical methods
All diet, orts, and fecal samples were dried at 60 °C to a
constant weight and were ground to a particle size of
1 mm. Urine samples were thawed, sieved through cot-
ton gauze, and filtered with glass wool. Urine, diet, and
fecal samples were analyzed in duplicate for nitrogen (N;
method 990.03 [17]; TruMac®; LECO Corp., St. Joseph,
MI, USA). An EDTA sample (9.56% N) was used as the
standard for calibration and was determined to be (9.55
± 0.01)% N. Crude protein (CP) was calculated as N ×
6.25. Diets were analyzed for mannan (Galactomannan
Assay Kit, Megazyme International, Wicklow, Ireland)
and β-mannanase concentration (colorimetric determin-
ation, Elanco Animal Health, Gaithersburg, MD).
Diet and fecal samples were analyzed in duplicate for
dry matter (DM; method 930.15), acid hydrolyzed ether
extract (EE; method 2003.06), and starch (Total Starch
Assay Kit, Megazyme International, Wicklow, Ireland,
method 996.11) using standard methods [17]; and in
triplicate for neutral and acid detergent fiber compo-
nents (NDF [18] and ADF [19], respectively). Hemicellu-
lose was calculated as the difference between NDF and
ADF concentrations. Gross energy (GE) was determined
using a bomb calorimeter (model 6200; Parr Instrument
Co., Moline, IL). Benzoic acid (6,318 kcal GE/kg; Parr
Instrument Co.) was used as the standard for calibration
and was determined to contain 6,325 ± 6.9 kcal GE/kg.
Urine GE was calculated as 192 plus 31 times the con-
centration of urinary N [20] and multiplied by a factor
of 0.239 to convert the unit to kcal.
Pre- and post-challenge whole blood samples and
blood smears were analyzed for CBC performed by
Manitoba Veterinary Diagnostic Services (Winnipeg,
MB, Canada) using Advia 2120i (Siemens Healthcare
Diagnostics, Tarrytown, NY, USA) with a manual differ-
ential. The main response variables of interest were total
cell, RBC, and WBC (mature and immature neutrophils,
Table 2 Experimental diet ingredient and analyzed nutrient
composition (as-fed basis)
Item Control diet Enzyme diet





Soybean hulls 10.00 10.00
Soybean oil 1.85 1.85
Limestone 1.04 1.04
Monocalcium phosphate 0.60 0.60
Vitamin premixa 0.33 0.33
Trace mineral premixb 0.20 0.20
Salt 0.25 0.25
Hemicell HT-Dc 0.00 0.06
Calculated composition, % of diet
SID Lys 1.18 1.18
SID Met 0.32 0.32
SID Thr 0.75 0.75
SID Trp 0.26 0.26
SID Cys + Met 0.62 0.62
β-mannane 1.33 1.33
Analyzed composition, % of diet
DM 86.75 87.17






endo-1,4-β-mannanasef, IU/kg Below detectable limitg 150,000
aProvided per kilogram of complete diet: 6,614 IU of vitamin A; 827 IU of
vitamin D; 26 IU of vitamin E; 2.6 mg of vitamin K; 29.8 mg of niacin; 16.5 mg
of pantothenic acid; 5.0 mg of riboflavin; 0.023 mg of vitamin B12
bProvided per kilogram of complete diet: Zn, 165 mg as ZnSO4; Fe, 165 mg as
FeSO4; Mn, 39 mg as MnSO4; Cu, 17 mg as CuSO4; I, 0.3 mg as Ca (IO3)2; and
Se, 0.3 mg as Na2SeO3
cHemicell™ HT-D, Elanco Animal Health, Guelph, ON, Canada; endo-1,4-β-mannanase
(160 × 106 units/kg) from Paenibacillus alvei
dAcid hydrolyzed ether extract
eβ-mannan concentration was calculated using values reported in Shastak
et al. [70]
fendo-1,4-β-mannanase activity. 1 IU = the amount of enzyme which generates
0.72 micrograms of reducing sugars per minute from a mannose-containing
substrate at pH 7.0 and temperature of 40 °C
gThe lowest detectable limit was 15,000 IU/kg
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eosinophils, basophils, lymphocytes, and monocytes)
concentrations.
Serum was divided into three subsamples. One set was
analyzed for glucose and insulin concentrations by Animal
Health Laboratory (University of Guelph, ON, Canada).
Glucose concentration was determined on an automated
Roche Cobas C501 analyzer (GLUC3 application, Roche
Diagnostics, Indianapolis, IN, USA) and insulin concen-
tration was quantified using commercial RIA kits (PI-12 K,
EMD Millipore, Billerica, MA, USA). The second serum
subset was analyzed for cytokine concentrations (granulo-
cyte macrophage colony-stimulating factor (GM-CSF),
tumor necrosis factor alpha (TNFα), Interleukin (IL)-o-
ne-alpha (IL-1α), IL-1β, IL-one-receptor antagonist
(IL-1ra), IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, and IL-18) by
a commercial multiplex assay using laser bead tech-
nology (Eve Technologies, Calgary, AB, Canada). The
third serum set was analyzed for concentration of APPs
haptoglobin and mannose-binding lectin A (MBL) using
porcine-specific commercial ELISA kits (Immunology
Consultants Laboratory, Inc., Portland, OR, USA; MyBio-
Source, Inc., San Diego, CA, USA, respectively).
Calculations
Dry matter, GE, CP, EE, starch, hemicellulose, NDF, and
ADF apparent total tract digestibility (ATTD; %) were
calculated on a DM basis as [(nutrient intake – nutrient
output in feces)/nutrient intake] × 100. Digestible energy
(DE) content of the diet was calculated as GE × GE
ATTD. Dietary ME was calculated according to the
equation of Noblet et al. [21]: ME = DE – [urine GE +
(0.4% of DE intake)]. Nitrogen retention (NR) was calcu-
lated by the difference between N intake and N excreted
in the feces and urine, and protein deposition (PD) was
determined as NR × 6.25.
Heat production was calculated from respiratory gas
exchanges and urinary N production according to the
equation of Brouwer [22]: HP (kcal) = 3.87 × VO2 con-
sumed (L) + 1.20 × VCO2 produced (L) – 1.43 × urinary
N production (g). Methane production was not
accounted for, but has been estimated to be very low in
growing pigs (< 1% [23]). All HP parameters were nor-
malized to a period of 24 h, expressed as kcal of heat
produced per kg of BW0.60 [24] and per kg of DM intake
(DMI) in order to remove known effects of variations in
BW and DMI [25, 26].
Total heat production (HPtotal) was the average HP
during the 22 h of post-challenge, fed state measure-
ment. Total fasting heat production (FHPtotal) was the
average HP over the 12 h fasted-state. Because the sys-
tem was not equipped to quantify and separate HP due
to physical activity, fasting heat production (FHP) was
derived from the 10 lowest HP values over the
fasted-state, reflecting energy metabolism due to basal
metabolic rate and not associated with feed consump-
tion, digestion, or physical activity [27, 28]. The respira-
tory quotient (RQ) was calculated as VCO2 divided by
VO2 during the fed (RQfed) and fasting (RQfast) states.
To best estimate components of HP not attributed to
the basal metabolic rate, HP values for physical activity
and the thermic effect of feeding (TEF) were calculated.
Activity heat production (AHP) was estimated utilizing
fed-state HP data measured over 10 h post-challenge to
represent normal post-feeding daytime behavior. The
difference between the average HP over this 10 h period
(HP10) and the average of the 10 lowest HP values over
the same time (HPlow; representative of sedentary, rest-
ing behavior; [27, 28]) was designated as AHP. The TEF
was calculated as the difference between HP10 and the
sum of AHP and FHP, so that any HP in excess of basal
metabolism and activity was partitioned toward TEF.
Heat increment (HI) was then calculated as the sum of
AHP and TEF. Using these data, the efficiency of utiliz-
ing ME for maintenance and growth (kmg, %) was calcu-
lated as (1 – HI / ME intake) × 100 [25, 29]. To address
the primary research question of how an immune chal-
lenge and β-mannanase supplementation impact main-
tenance energy requirements, metabolizable energy used
for maintenance (MEm) was then calculated as FHP ×
100/ kmg [25, 29].
Together, dietary energy, N balance, and HP values
were utilized to characterize energy use and balance in
the pig. Retained energy (RE) was calculated by the dif-
ference of ME intake and the total HP during the 24 h
fed-state (both pre- and post-challenge) to account for
all energy not available for tissue accretion [29]. Energy
retained as protein (REp) was calculated from N balance
assuming a PD (g) energy value of 5.64 kcal/g [30]. En-
ergy retained as lipid (REl) was calculated as the differ-
ence between RE and REp [30]. Lipid deposition (LD)
was then determined from REl assuming an energy con-
tent of 9.49 kcal/g of deposited lipid [22]. Dietary net en-
ergy (NE; kcal/kg) was calculated as the sum of RE and
FHP divided by DMI [21].
Statistical analyses
Data were analyzed as a randomized complete block de-
sign with pig as the experimental unit. The UNIVARI-
ATE procedure of SAS (Version 9.4, SAS Inst., Cary,
NC) was used to verify normality and homogeneity of
variances. Statistical outliers (> 3 SD away from the
mean) were removed; therefore, one pig from the ISS
treatment was removed from HP data because of poor
feed intake on the day of HP measurement. Immature
neutrophil, eosinophil, and basophil CBC data were log
transformed to achieve a normal distribution.
The main effects of dietary treatment and block were
analyzed using the MIXED procedure of SAS. The
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staggered block experimental design resulted in varia-
tions in time and body weight among blocks. This vari-
ation was expected and resulted in statistical detection
of block as a significant main effect in most response
variables. Therefore, block remained in the statistical
model, but block P-values are not reported herein.
Differences among treatments were determined using
ANOVA and means were separated using the least square
means statement and the PDIFF option. Immune and rectal
temperature data were analyzed as repeated measures
and covariance structures resulting in the lowest AIC
values for each variable were applied. To further
evaluate β-mannanase effects on immune parameters
pre-challenge, contrasts comparing CON versus ENZ
and ISS values were generated using the contrast
statement of the MIXED procedure. Differences were
considered significant if P was ≤0.05 and a trend if P
was > 0.05 and ≤ 0.10.
Results
Immune response parameters
Immune system stimulation effects
Pigs on the ISS treatment exhibited minimal vomiting,
diarrhea and signs of lethargy and hyperventilation after
the first and to a lesser extent, the second LPS injection.
After the third and fourth challenges, ISS pigs continued
to demonstrate signs of lethargy and hyperventilation, but
vomiting and diarrhea were not observed. No pigs died
after any injection. The immune stimulation model suc-
cessfully induced a sustained febrile response (rectal
temperature ≥ 40 °C) in ISS pigs on d 10, 12, and 14 (treat-
ment by day interaction P < 0.0001; Fig. 1). Pigs in CON
and ENZ treatments maintained normal rectal tempera-
tures (38.85 °C ± 0.15) throughout the experiment.
There was a significant interaction between the effects
of time (pre- or post-challenge) and treatment on WBC,
mature neutrophil, lymphocyte, and monocyte counts and
a trend for an interaction on RBC count (Additional file 2:
Table S2). In all four variables, treatments had similar cell
counts at the pre-challenge time point (P ≥ 0.10).
Post-challenge, immune stimulation by LPS decreased
WBC, mature neutrophil, lymphocyte, and monocyte
counts compared to CON and ENZ (P ≤ 0.05; Fig. 2).
There were no differences among treatments or time pe-
riods for total cell, immature neutrophil, eosinophil, or
basophil counts (P > 0.10; Additional file 2: Table S2).
Glucose, insulin, haptoglobin, and MBL serum con-
centrations were not affected by the interaction of time
and treatment (P > 0.10), but concentrations were higher
pre-challenge compared to post-challenge for glucose,
haptoglobin, and MBL (Additional file 3: Table S3).
Lipopolysaccharide challenge increased IL-1β, IL-1ra,
IL-6, IL-8, and TNFα concentrations post-challenge
compared to ISS pre-challenge and both pre- and
post-challenge concentrations in CON and ISS (Fig. 3).
All other cytokines were not significantly impacted by
the interaction or main effects of time and treatment
(P > 0.10; Additional file 3: Table S3). Interferon-gamma
was not detected in any of the samples. Serum GM-CSF
concentrations were not different (P > 0.10) among CON
and ENZ pre-and post-challenge and ISS pre-challenge,
while ISS post-challenge GM-CSF concentration was in-
creased compared to the ISS pre-challenge value and
CON and ENZ post-challenge values (P ≤ 0.015; Fig. 3).
Fig. 1 Effect of treatment on young weaned pig (n = 10 per treatment) rectal temperature (°C). Control treatment (CON) = pigs fed basal diet
(0.0% β-mannanase) with saline injection. Enzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with saline injection. Immune
system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with LPS (Escherichia coli serotype O55:B5) injection. The arrows
indicate days on which either a saline (CON and ENZ) or LPS (ISS) injection were administered at 10:00 h. Rectal temperatures were measured 4 h
post-challenge. Data points on d 5 and 8 represent average baseline pre-challenge temperature, and d 10, 12, and 14 represent post-challenge
temperatures. Treatment by day interaction P < 0.0001; day P < 0.0001; treatment P < 0.0001; block P = 0.0015
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β-mannanase effects
Contrasts comparing immune cell dynamics of pigs fed ei-
ther the control or β-mannanase diet prior to the first
challenge on d 10 detected no differences in CBC values
(P ≥ 0.10; Table 3). Similarly, serum glucose, insulin, MBL,
and cytokine concentrations (except IL-1α) did not differ
because of β-mannanase supplementation (P ≥ 0.230;
Table 4). Serum haptoglobin and IL-1α concentrations
were decreased in diets supplemented with β-mannanase
(P ≤ 0.05; Table 4).
Pig growth performance, nitrogen balance, and diet
digestibility
Average initial BW was 10.27 ± 0.15 kg, d 16 average
BW was 15.12 ± 0.27 kg, and BW did not differ among
treatments at either time point (P ≥ 0.471). Average daily
gain (ADG) over the entire 16-d experiment was not dif-
ferent among treatments (P = 0.13; Table 5), but ISS
ADG during the immune challenge (d 10–16) was less
than CON and ENZ gain (P = 0.010; Table 7).
Immune system simulation numerically decreased ADFI
and thus N intake compared to CON and ENZ (P =
0.021), resulting in decreased fecal N excretion on a g per
d basis (P = 0.007). Urine N excretion during the challenge
period was similar among treatments (P = 0.045), but
retained N in the ISS treatment was less than that of
CON, with ENZ being intermediate (P = 0.045; Table 5).
Partitioning of excreted N to either the feces or urine was
not different among treatment (P = 0.78). When N excre-
tion was expressed as a percent of N intake, the previously
observed significant treatment effect on fecal N excretion
was no longer evident (Table 5). There were no differences
among treatments in ATTD of any analyzed nutrient (P ≥
0.120; Table 6) and all ATTD coefficients were within nor-
mal ranges for 10 to 15 kg pigs.
Heat production, maintenance energy requirements, and
energy retention
Day 16 ME intake was similar among treatments
(759.4 ± 37.7 kcal/kg BW0.60/kg DMI/d; P = 0.92). Im-
mune system stimulation increased fed state HPtotal
Fig. 2 Effect of treatment on complete blood count before (d 8) and after (d 10) challenge. Serum was collected at 14:00 h each day (4 h post-
challenge). Control treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with saline injection. Enzyme treatment (ENZ) = pigs fed enzyme
diet (0.056% β-mannanase) with saline injection. Immune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with
LPS (Escherichia coli serotype O55:B5) injection. n = 10 per treatment. a,bWithin a graph, bars without a common superscript differ, P < 0.05
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compared to CON and ENZ (P = 0.040; Table 7). In
the fasting state, neither immune stimulation nor
β-mannanase supplementation affected FHPtotal or
FHP compared to control (P ≥ 0.135). Treatment did
not affect RQ in the fed and fasting states (P ≥ 0.23;
Table 7).
Immune system stimulation increased MEm (kcal/kg
BW0.60/kg DMI/d) compared to CON or ENZ pigs
(P = 0.045), but kmg among treatments did not differ
(P = 0.13; Table 7). When MEm was expressed as
kcal/d, the significant treatment effect was no longer
detected (P = 0.90). Beta-mannanase supplementation
Fig. 3 Effect of treatment on serum cytokine concentrations before (d 8) and after (d 10) challenge. Serum was collected at 14:00 h each day (4 h
post- challenge). Control treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with saline injection. Enzyme treatment (ENZ) = pigs fed enzyme
diet (0.056% β-mannanase) with saline injection. Immune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056% β-mannanase) with LPS
(Escherichia coli serotype O55:B5) injection. n = 10 per treatment. a,bWithin a graph, bars without a common superscript differ, P < 0.05
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did not change MEm relative to CON whether
expressed as kcal/kg BW0.60/kg DMI/d (P = 0.98),
kcal/kg BW/d (P = 0.72), or kcal/d (P = 0.77).
Absorbed energy not lost via urine, gases, heat in-
crement, activity and TEF, or maintenance, is
retained as either protein or lipid. Immune system
stimulation decreased REl compared to CON and
ENZ (P = 0.046) but REp and total RE were not dif-
ferent among treatments (P > 0.32) when expressed as
kcal/kg BW0.60/kg DMI/d (Table 7). When RE was
expressed as a proportion of ME intake, similar treat-
ment effects were observed for REl and REp, but a
significant decrease in total RE was detected due to
ISS (P = 0.033; Table 7). As less energy was retained
as lipid, LD was decreased in the ISS treatment com-
pared to CON and ENZ (P = 0.047) while no differ-
ences were observed in PD (P = 0.15; Table 7).
Dietary energy values and efficiency
The ENZ and ISS treatments tended to decrease diet DE
and ME values relative to CON (P ≤ 0.052; Table 8). Nei-
ther ISS nor β-mannanase supplementation (ENZ treat-
ment) affected dietary NE value (P = 0.75) or ME and
NE efficiency (P ≥ 0.46).
Discussion
During an immune challenge, pro-inflammatory cyto-
kines initiate a shift in nutrient partitioning away from
tissue growth to support activation and maintenance of
an immune response [1, 11, 31]. The results of this ex-
periment clearly demonstrated that a systemic inflam-
matory response to LPS occurred, verified by increased
concentrations of pro-inflammatory cytokines and ele-
vated body temperature. To our knowledge, these data
are the first to directly relate decreased ADG to in-
creased MEm independent of changes in feed intake dur-
ing an immune response. Additionally, this experiment
provides novel data on β-mannanase supplementation
Table 3 Complete blood count values in young weaned pigs
fed a diet with or without β-mannanasea,b
Treatment Control dietc β-mannanase dietd Contrast
P-valueEstimate SEM Estimate SEM
Cell type count, cells × 109/Le
Total cells 468.6 34.9 432.4 23.8 0.405
WBC 24.50 1.43 21.51 0.98 0.104
Neut 6.47 0.94 6.83 0.64 0.758
Bands 0.200 0.050 0.266 0.034 0.504
Eos 0.202 0.099 0.300 0.068 0.599
Baso 0.048 0.061 0.100 0.042 0.451
Lymph 15.35 1.46 12.46 1.00 0.124
Mono 0.727 0.181 0.709 0.123 0.934
RBC 7.44 0.14 7.55 0.09 0.547
aBlood was collected on d 8 of the experiment 6 h post-feeding, prior to the
immune challenge beginning on d 10
bn = 10 pigs per treatment
cControl diet was a corn, soybean mean, and soy hulls based diet containing
1.33% β-mannans, and did not contain β-mannanase enzyme. Pigs on the
control (CON) treatment were fed the control diet and estimates are
representative of the CON treatment only
dEnzyme diet was the control diet supplemented with 0.056% β-mannanase
(Hemicell™ HT-D, Elanco Animal Health, Guelph, ON, Canada; endo-1,4-β-
mannanase (160 × 106 units/kg) from Paenibacillus alvei). Pigs on the
enzyme (ENZ) and immune system stimulation (ISS) treatments were fed
the enzyme diet. Estimates are representative of the ENZ and ISS treatments prior
to immune stimulation
eBasophils (Baso); eosinophils (Eos); immature neutrophils (Bands);
lymphocytes (Lymph); mature neutrophils (Neut); monocytes (Mono);
white blood cells (WBC)
Table 4 Effect of β-mannanase on pig serum glucose, insulin,
acute phase protein, and cytokine concentrationsa,b
Treatment Control dietc Enzyme dietd Contrast
P-valueEstimate SEM Estimate SEM
Glucose, mmol/L 7.70 0.46 7.41 0.25 0.585
Insulin, pmol/L 88.92 10.99 83.35 6.06 0.664
Insulin:Glucose 11.56 1.21 11.08 0.67 0.734
Acute phase protein, mg/mL
Haptoglobin 1.57 0.22 1.02 0.14 0.050
MBLe 125.4 8.6 117.5 5.2 0.445
Cytokine, pg/mLf
GM-CSF 17.01 13.01 14.56 7.85 0.874
IL-1α 35.01 6.81 7.50 4.27 0.004
IL-1β 1064 598 1138 361 0.917
IL-1ra 428.6 257.5 673.7 161.5 0.435
IL-2 328.4 157.6 228.8 95.0 0.596
IL-4 995.5 545.6 711.6 329.0 0.662
IL-6 190.2 61.5 98.72 38.59 0.230
IL-8 263.1 95.4 402.2 57.5 0.230
IL-10 499.4 159.1 332.9 95.9 0.383
IL-12 1570 173 1730 104 0.439
IL-18 1994 546 1380 329 0.350
TNFα 24.29 39.90 52.30 25.02 0.563
aBlood was collected on d 8 of the experiment 6 h post-feeding, prior to the
immune challenge beginning on d 10
bn = 10 pigs per treatment
cControl diet was a corn, soybean mean, and soy hulls based diet containing
1.33% β-mannans, and did not contain β-mannanase enzyme. Pigs on the
control (CON) treatment were fed the control diet and estimates are
representative of the CON treatment only
dEnzyme diet was the control diet supplemented with 0.056% β-mannanase
(Hemicell™ HT-D, Elanco Animal Health, Guelph, ON, Canada; endo-1,4-β-
mannanase (160 × 106 units/kg) from Paenibacillus alvei). Pigs on the enzyme
(ENZ) and immune system stimulation (ISS) treatments were fed the enzyme
diet. Estimates are representative of the ENZ and ISS treatments prior to
immune stimulation
eMannose binding lectin A (MBL)
fGranulocyte-macrophage colony-stimulating factor (GM-CSF); interleukin-1α
(IL-1α); interleukin-1β (IL-1β); interleukin-1 receptor antagonist (IL-1ra);
interleukin-2 (IL-2); interleukin-4 (IL-4); interleukin-6 (IL-6); interleukin-8 (IL-8);
interleukin-10 (IL-10); interleukin-12 (IL-12); interleukin-18 (IL-18); tumor
necrosis factor alpha (TNFα)
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Table 5 Growth performance and nitrogen balance in pigs on
control, enzyme, or immune system stimulation treatmentc
Item CONd ENZe ISSf SEM Treatment
P-value
Body Weight, kg
d 0 10.23 10.21 10.38 0.15 0.651
d 16 15.25 15.26 14.86 0.27 0.471
ADG d 1–16, g/d 313.9 316.0 279.7 13.6 0.128
Nitrogen (N) balance, g/d
Intake 21.02a 20.93a 17.38b 0.95 0.021
Excreted 6.21 7.08 6.24 0.45 0.318
In feces 2.62a 2.83a 2.27b 0.11 0.007
In urine 3.59 4.25 3.97 0.47 0.624
Retained 14.81a 13.85ab 11.14b 0.99 0.045
% of excreted N in feces 41.31 41.21 38.42 3.29 0.778
% of excreted N in urine 58.69 58.79 61.58 3.29 0.778
Nitrogen balance, % of intake
Excreted in feces 12.41 13.54 13.23 0.44 0.212
Excreted in urine 17.38 21.40 24.56 4.14 0.495
a,bWithin a row, treatment means without a common superscript differ, P < 0.05
cn = 10 pigs per treatment
dControl treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with
saline injection
eEnzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with
saline injection
fImmune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056%
β-mannanase) with LPS (Escherichia coli serotype O55:B5) injection
Table 6 Apparent total tract digestibility in pigs on the control,
enzyme, or immune system stimulation treatmenta
Item CONb ENZc ISSd SEM Treatment
P-value
ATTDe, %
DM 88.05 87.36 87.66 0.33 0.356
GE 87.35 86.73 86.86 0.33 0.418
CP 87.59 86.47 86.77 0.44 0.212
EEf 70.41 69.62 66.85 1.18 0.122
Starch 99.41 99.50 99.56 0.10 0.565
NDF 68.81 66.11 70.23 1.55 0.178
ADF 71.65 68.04 74.13 2.26 0.175
Hemicelluloseg 65.00 63.51 64.99 0.92 0.429
an = 10 pigs per treatment
bControl treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with
saline injection
cEnzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with
saline injection
dImmune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056%
β-mannanase) with LPS (Escherichia coli serotype O55:B5) injection
eATTD, % = [(nutrient intake (kg) – fecal nutrient output (kg)) / nutrient
intake (kg)] × 100
fAcid hydrolyzed ether extract
gHemicellulose = NDF - ADF
Table 7 Effect of treatment on energy balance, respiratory
quotient, maintenance energy requirements, and nutrient
depositionc
Treatment Treatment
P-valueItem CONd ENZe ISSf SEM
Day 16 BW, kg 14.37 14.19 13.77 0.26 0.313
Day 16 DMI, kg 0.51 0.51 0.46 0.03 0.348
Energy balance, kcal/kg BW0.60/kg DMI/d
ME intake 771.3 755.9 751.1 37.7 0.924
Heat productiong
HPtotal 278.8
b 274.9b 333.0a 14.9 0.040
FHPtotal 287.8 276.0 324.3 17.1 0.178
FHP 207.8 206.6 243.3 12.9 0.135
Retained energyh
As protein 197.5 173.6 191.0 18.3 0.627
As lipid 291.4a 302.9a 227.7b 19.2 0.046
Total 488.9 476.5 418.7 32.0 0.318
kmg, % 87.07 86.44 83.01 1.34 0.130
Estimated MEm 239.0
b 239.5b 295.5a 15.3 0.045
Retained energy, % of ME intake
As protein 25.68 23.15 24.99 1.27 0.354
As lipid 37.77a 40.07a 29.81b 2.02 0.013
Total 63.44a 63.22a 54.80b 2.18 0.033
Respiratory quotient
Fed state 0.92 0.90 0.88 0.01 0.225
Fasting state 0.74 0.73 0.73 0.01 0.381
Nutrient depositioni, g/d
As protein 87.74 78.55 69.80 5.86 0.150
As lipid 76.22a 79.43a 55.45b 6.21 0.047
ADG d 10–16, g/d 447.1a 404.8a 330.7b 21.3 0.010
a,bWithin a row, treatment means without a common superscript differ, P < 0.05
cn = 7 pigs per treatment (CON and ENZ) and 6 pigs per treatment (ISS)
dControl treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with
saline injection
eEnzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with
saline injection
fImmune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056%
β-mannanase) with LPS (Escherichia coli serotype O55:B5) injection
gHeat production (HP) = (3.87 × O2 consumption (L) + 1.20 × CO2 production (L)
– 1.43 × urinary N)/BW0.60 (kg) [22]; Total HP (HPtotal) = avg. HP over 22 h fed
state, post- challenge; Total fasting HP (FHPtotal) = avg. HP over 12 h fasted
state; Fasting HP (FHP) = avg. of 10 lowest HP values over the 12 h fasted state
[27, 28]; HP10 = avg. HP over 10 h post-challenge (10:00 h – 20:00 h), fed state;
HPlow = avg. of 10 lowest HP values over 10 h post-challenge (10:00 h –
20:00 h), fed state; Activity HP (AHP) = HP10 - HPlow; Thermic effect of feeding
(TEF) = HP10 - AHP – FHP; Heat increment (HI) = AHP + TEF; ME efficiency for
maintenance and growth (kmg) = (1 – HI) × 100 [25]; ME used for maintenance
(MEm) = FHP × 100/kmg [25]
hRetained energy (RE) = ME intake – total fed-state HP, pre-and post-challenge
[29]; RE as protein (REp) = [PD (g) × 5.66 (kcal/g)]/ BW
0.60/DMI [30]; RE as lipid
(REl) = RE - REp [30]
iProtein deposition = nitrogen retention (g) × 6.25; Lipid deposition = REf (kcal)
/ 9.49 (kcal/g) [30]
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effects on immune parameters and energy balance in
pigs.
β-mannanase
As a constituent of hemicellulose, β-mannan is not
digested by mammalian endogenous enzymes [32]. Thus,
intact β-mannans are available to bind carbohydrate rec-
ognition domains of pattern recognition receptors on in-
nate immune cells surveying the intestinal epithelium
for potential pathogens [3, 33]. In this way, β-mannans
are hypothesized to be capable of stimulating innate im-
mune cells resulting in a nonproductive, energy draining
immune response [4–6].
Commonly, only growth and feed efficiency responses
have been measured from β-mannanase and reported in
the animal nutrition literature. Reduced feed efficiency
and ADG have been reported with increasing dietary
β-mannan concentrations [34]. Therefore, there is interest
in β-mannanase supplementation to alleviate these nega-
tive effects by enzymatic hydrolysis of β-mannan polysac-
charides. The FIIR was alleviated through β-mannanase
supplementation in poultry [6, 35]; however, β-mannanase
supplementation responses in swine have been inconsist-
ent. This experiment demonstrated no β-mannanase effect
on the ATTD of DM, GE, CP, EE, or hemicellulose.
Growth performance responses are similarly inconsistent
with positive results in some studies [36–38] but no
β-mannanase effect in others [39–42]. In this experiment,
ENZ did not improve ADG, protein, or lipid deposition.
Dietary β-mannans are proposed to stimulate the in-
nate immune system through direct interactions with
the carbohydrate binding domains of mannose recogni-
tion receptors such as the membrane bound mannose
receptor and secreted MBL. Therefore, serum MBL con-
centrations were measured to determine if β-mannanase
supplementation decreased circulating MBL, theoretic-
ally by removing the substrate for activation and synthe-
sis. Serum MBL concentrations were not affected by
β-mannanase. This may indicate that the β-mannan con-
centration in the intestinal lumen was not high enough
to either interact with MBL, MBL-dietary β-mannan
interaction was not affected by β-mannanase supple-
mentation, or this interaction is not a mechanism
through which β-mannans are sensed by the innate im-
mune system.
Two significant differences in serum parameters
were detected when contrasts were applied to com-
pare pre-challenge values between control pigs (no
β-mannanase, CON treatment) and β-mannanase
supplemented pigs (ENZ and ISS treatments).
Beta-mannanase supplementation decreased serum
haptoglobin and IL-1α concentrations. In poultry,
decreased haptoglobin has been proposed as evidence of
immune stress alleviation due to β-mannanase supplemen-
tation [6]. However, this response occurred in conjunction
with growth performance and feed efficiency improvements
which were not observed in this study. Beta-mannanase
effects on IL-1α concentrations have not been previously
reported. Interleukin-1-alpha can be involved in inflamma-
tion initiation, but the relationship between serum concen-
tration and magnitude of immune challenge is not as clear
as the implication of its counterpart, IL-1β on systemic in-
flammation [43]. Interleukin-1-beta concentrations were
not affected by β-mannanase supplementation in this study.
In total, decreased serum IL-1α and haptoglobin con-
centrations are not strong enough evidence of an allevi-
ated systemic FIIR when taken in context with the lack
of all other measured inflammatory-type variables. Im-
portantly, no differences were observed in HP, MEm, and
growth performance. It is possible that a localized re-
sponse may have occurred at the intestinal level yet went
undetected systemically. However, if this occurred, whole
body nutrient and energy partitioning were still un-
affected. The hypothesis that β-mannanase supplementa-
tion would decrease MEm was not supported. Pigs fed
diets supplemented with β-mannanase had similar WBC
counts, cytokine concentrations, nutrient digestibility,
ADG, N and energy balance, PD, LD, and MEm com-
pared to CON pigs.
Immune stimulation
Innate immune stimulation was successfully induced in
pigs using sequential, increasing doses of E. coli LPS. El-
evated rectal temperature, increased pro-inflammatory
cytokine concentrations, and altered nutrient and energy
partitioning are all hallmarks of a chronic immune chal-
lenge [1] and were observed in ISS pigs in this study.
Table 8 Dietary energy values and efficiency in pigs on control,
enzyme, or immune system stimulation treatmenta
Treatment Treatment
P-valueItem CONb ENZc ISSd SEM
Dietary energy valuee, Mcal/kg DM
GE 4.65 4.59 4.59
DE 4.07 3.99 4.00 0.02 0.051
ME 3.96 3.86 3.89 0.03 0.052
NE 3.29 3.30 3.11 0.19 0.748
ME/DE efficiency, % 97.31 96.92 97.35 0.37 0.457
NE/ME efficiency, % 83.09 85.31 80.03 4.42 0.701
an = 7 pigs per treatment (CON and ENZ) and 6 pigs per treatment (ISS)
bControl treatment (CON) = pigs fed basal diet (0.0% β-mannanase) with
saline injection
cEnzyme treatment (ENZ) = pigs fed enzyme diet (0.056% β-mannanase) with
saline injection
dImmune system stimulation treatment (ISS) = pigs fed enzyme diet (0.056%
β-mannanase) with LPS (Escherichia coli serotype O55:B5) injection
eGross energy (GE) analyzed via bomb calorimetry; digestible energy (DE) = GE
apparent total tract digestibility coefficient × diet GE; metabolizable energy
(ME) = DE – (urinary energy + 0.4% of DE intake); net energy (NE) = (retained
energy + fasting heat production)/DMI
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One limitation of this study was the number of calorim-
etry chambers available which limited the experiment to
a total of three treatments. Due to this limitation, we
were unable to evaluate the interaction of β-mannanase
supplementation with LPS immune stimulation. Thus,
interpretation of ISS effects has been made in compari-
son to the ENZ treatment. However, as discussed above,
there were no differences between the CON and ENZ
treatments in nutrient digestibility, ADG, or N and en-
ergy balance. The major finding of this research indi-
cates that the innate immune challenge increased young
pig maintenance energy requirements by 23.3% which
translated into a 18.3% decrease in ADG.
Unique to this study, decreased ADG could be attrib-
uted primarily toward increased MEm in ISS pigs as op-
posed to decreased feed intake or effects on nutrient
digestibility. Anorexia is a well-established response to
systemic immune stimulation [2, 9, 44] induced by
pro-inflammatory cytokine actions (especially IL-1β) in
the brain and modulation of metabolism and hormone
release [45]. In this study, a numerical but not statisti-
cally significant decrease in ADFI was observed in ISS
pigs during the challenge period even though IL-1β in-
creased. It is likely that a stronger ADFI decrease was
not observed as a consequence of challenging the pigs
2 h post-feeding and limit feeding to 2.5 times mainten-
ance energy requirements [12]. This feeding level was
designed to achieve similar ADFI for pigs on all treat-
ments because of the known effect of previous feeding
level on HP [25]. To further ensure HP results were sep-
arated from feed intake and BW effects, all energy bal-
ance calculations were conducted on a kcal/BW0.60/
DMI/d basis. Just as feed intake did not influence the
observed decrease in ADG of ISS pigs, nutrient digest-
ibility was not different across treatments. This is in
agreement with other studies reporting ATTD during a
chronic LPS challenge [46, 47].
Febrile response
Before the challenge period, rectal temperatures and
blood immune parameters in ISS pigs were not different
from those on the CON and ENZ treatments. This con-
firmed that prior to the challenge all pigs were in good
health and of similar immune status. Therefore, any sub-
sequent differences during the challenge were attributed
to LPS immune stimulation. Elevated rectal tempera-
tures (> 40 °C) post-challenge on d 10, 12, and 14 indi-
cated a febrile response in ISS pigs.
Fever is energetically expensive with increased caloric
requirement estimates ranging from 7 to 15% for each
1 °C increase in body temperature [48]. Utilizing the
average rectal temperature of CON and ENZ pigs and
the post-challenge temperature of ISS pigs on day 14, an
increase of 1.2 °C resulted in a 23.6% increase in MEm
caloric requirements. This value is higher than the previ-
ously described range and may indicate that the major-
ity, but not all of the increase in maintenance caloric
requirement is to support the febrile response. The re-
mainder may be partially explained by an increase in im-
mune cell glucose requirements [11].
Cytokines
Key pro-inflammatory cytokines include TNFα, IL-6,
and IL-1β [49] and ISS pigs had increased serum con-
centrations of all three after the first LPS challenge.
Pro-inflammatory cytokines shift metabolism away from
anabolic processes toward a more catabolic state to gen-
erate AAs and energy necessary to support fever, in-
crease immune cell proliferation, and APP synthesis [50,
51]. In this study, the pro-inflammatory cytokine profile
of ISS pigs clearly shifted metabolism toward a lipolytic
state and this resulted in significantly less energy
retained as lipid and decreased lipid deposition com-
pared to non-immunologically challenged pigs.
Complete blood count
Immune stimulation decreased WBC counts, specifically
neutrophils, lymphocytes, and monocytes. This is similar
to other instances of leukopenia observed due to LPS ad-
ministration [11, 52]. However, WBC distribution drastic-
ally changed following LPS administration and circulating
concentrations are dependent upon the time of sampling
relative to immune challenge [52, 53]. Thus, variable re-
sponses in WBC counts have been reported due to LPS
immune stimulation. Rakhshandeh and de Lang observed
1.6 times greater WBC [8] in one study, but in a second,
WBC count decreased by 9% [54]. At the time of sampling
in this study, leukocyte extravasation into the LPS injec-
tion site and into immunologically important tissues likely
explains the observed leukopenia.
Acute phase proteins
In addition to increased pro-inflammatory cytokine pro-
duction and leukocyte migration that occur during infec-
tion, the acute phase response typically includes
increased APP synthesis by the liver. However, in this
study, ISS APP concentrations did not differ compared
to CON. This was an unexpected result because LPS has
been demonstrated to increase APPs such as haptoglo-
bin [8, 46] and C-reactive protein [55] in pigs. A less re-
sponsive APP, MBL has been demonstrated to attenuate
LPS-induced pro-inflammatory cytokine production [56]
and inhibit T-lymphocyte activation [57]. However, in
this study it did not appear that LPS induced greater
MBL or haptoglobin production.
Although a MBL response was not necessarily ex-
pected, a haptoglobin response was. Haptoglobin is a
primary APP in pigs and is synthesized in the liver when
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activated by IL-6 and to a lesser extent IL-1 [58],
both of which were significantly elevated in ISS pigs
post-challenge. Similar to our results, Koopmans et al.
[55] discussed unpublished data which showed no
LPS effect on haptoglobin concentrations even though
there were clear increases in plasma cortisol, TNFα,
IL-6, and C-reactive protein over a 24-h period after
LPS challenge. One possible explanation for a lack of
haptoglobin response could be time related. Serum
samples in this study were collected 4 h after the first
challenge and haptoglobin may be a better indicator
of chronic inflammation [59].
Nitrogen balance
Disease is associated with decreased growth performance
and changes in nutrient partitioning. Often, N metabol-
ism is affected because of increasing AA requirements
for immune cell proliferation and APP synthesis [51]. In
this study, only numerical decreases in protein depos-
ition were measured in ISS pigs compared to CON and
ENZ. If protein catabolism had increased to provide
AAs for APPs, an increase in urinary N would have been
expected because APPs have a distinctly different AA
profile than skeletal muscle [50, 60]. However, due to
the high dietary CP concentration, it is possible that
these excessive dietary amino acids may have provided
the additional amino acids required for APP synthesis
and prevented the typically observed increase in skeletal
muscle protein catabolism.
Energy balance
Disease is well known to be detrimental to pig efficiency
and productivity. A considerable amount of research has
focused on products to mitigate the drop in performance
[13, 61] or prevent initial disease onset [62]. Yet few
studies have evaluated the energetic cost of an immune
challenge in order to generate more effective dietary in-
terventions. In this study, total HP increased by 21.1% in
ISS pigs compared to the ENZ treatment.
Campos et al. [46] also evaluated HP components
during an immune response and reported significant
decreases in ADFI leading to decreased TEF compared
to baseline values. In this study DMI did not differ, po-
tential feed intake effects on TEF were removed by inter-
preting the data after normalizing to a constant feed
intake, and TEF values were not affected by ISS. There-
fore, both experiments indicate that a chronic inflamma-
tory response did not increase HP through increased
TEF. This is supported by the lack of treatment differ-
ences in diet digestibility and further supports our sup-
position that the impact of immune stimulation on
energy balance in this study is not through influences on
diet digestion or nutrient uptake.
However, it is clear that energy partitioning between
maintenance and growth was affected by ISS. A 23.3%
increase in MEm was detected due to ISS. As caloric re-
quirements for maintenance increased to support the
immune system, less dietary energy was retained for
growth. This manifested as less REl resulting in a 30.2%
decrease in lipid deposition.
Previous studies across all species have related in-
creased caloric requirements with fever [48, 63], but few
have directly related a chronic immune challenge with
increased MEm. In vitro studies with isolated mitochon-
dria from rats stimulated with TNFα or IL-1 showed up
to 30% increases in respiration rate [64]. Demas et al.
[63] reported that mice injected with a mild antigen had
limited immune activation that resulted in significantly
more O2 consumption than control mice injected with
saline. Interleukin-six infusions in humans increased
resting metabolic rates by 25% [65].
In pigs, the direct relationship between immune
stimulation and increased energy requirements has not
previously been demonstrated. Some studies reported
that immune system stimulation did not impact growth,
efficiency, or energy balance measurements [66, 67]
However, Moon et al. [66] reported fibroblast formation
at the injection site which encapsulated the immunogen
and prevented systemic delivery. Williams et al. [67]
used the comparative slaughter technique and reported
no differences in the energetic costs of maintenance, PD,
and LD between pigs raised in environments encour-
aging high or low chronic immune activation.
Conversely, Labussière et al. [68] and Campos et al.
[46] reported decreased HP in pigs during inflammatory
challenges. Labussière et al. [68] administered a single
injection of complete Freund’s adjuvant to young
weaned pigs but did not measured HP until the day after
challenge and only re-entered the calorimetry chamber
after visual recovery [68]; and this likely biased the
response. Campos et al. [46] reported a 14% decrease in
total HP (kcal/BW0.60/d) in response to a repeated LPS
challenge in growing pigs even though typical
inflammatory-type and febrile responses were observed.
Decreased HP was mainly attributed to lower TEF which
reflected the effect of feed intake depression on HP. Ac-
cording to the relationship reported by Labussière et al.
[25], lower ADFI should have decreased MEm by
24 kcal/BW0.60/d. Because this drop in MEm did not
occur, the authors reasoned that the immune stimulation
did in fact increase MEm relative to baseline [46]. This
supports our experimental model of limit feeding to en-
courage similar feed intake and to evaluate energy bal-
ance on a kcal/BW0.60/DMI/d basis. Feed intake clearly
influences and can bias HP results and interpretations.
Interpretation of our results in context with the previ-
ously discussed reports suggests that an inflammatory
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response does increase MEm relative to healthy control
animals, but in some experiments this response may be
masked by decreased HP related to decreased feed in-
take. This may mean that during an immune response
the total caloric requirement may not drastically change
because of decreased feed intake, but how those calories
are partitioned does change; and this results in growth
and feed efficiency depressions commonly observed dur-
ing disease challenges.
These results supported our hypothesis that energy
partitioning shifts to allocate more energy for initiation
and maintenance of immune functions and less toward
nutrient deposition. Other research would support
changes in N metabolism [46, 67, 69] whereas our data
suggest that less energy was allocated for LD. Both result
in decreased ADG and efficiency losses in pork produc-
tion, yet these effects are generally given little consider-
ation in commercial swine feeding practices.
Conclusions
This experiment provides novel data on β-mannanase
supplementation effects on immune parameters and en-
ergy balance in pigs. Beta-mannanase supplementation
did not benefit immune status, nutrient digestibility,
growth performance, energy balance, or MEm in young
pigs fed a corn, soybean meal, and soybean hulls-based
diet. More research is needed to determine how
β-mannanase functions in pigs and in which environ-
ments and diets it might be effective. These novel data dir-
ectly relate decreased ADG to increased MEm
independent of changes in feed intake in immune chal-
lenged pigs. An innate immune challenge increased proin-
flammatory cytokine concentrations which induced a
febrile response and elevated HP and MEm by 23.3%. In-
creased energy partitioning toward the immune response
limited LD by 30.2% leading to a 18.3% decrease in ADG
during the immune challenge. These data expand upon
the available literature to describe the magnitude of in-
crease in MEm in immune challenged pigs relative to
healthy control animals. Understanding the extent to
which energy requirements and nutrient deposition
change in pigs experiencing sustained immune stress may
help develop more effective feeding strategies for health
challenged herds and encourage appreciation for the eco-
nomic benefits of maintaining high health populations.
Additional files
Additional file 1: Table S1. Pre-test diet ingredient and analyzed nutrient
composition. Table provides ingredient and nutrient composition of the
common, pre-test diet all pigs were fed prior to initiating experiment.
(DOCX 17 kb)
Additional file 2: Table S2. Effect of treatment on pre- and post-challenge
complete blood count values. Table provides LS means, time by treatment
P-values, time P-values, and treatment P-values, as well as means comparisons
results for complete blood count response variables. (DOCX 20 kb)
Additional file 3: Table S3. Effect of treatment on serum glucose,
insulin, acute phase protein, and cytokine concentrations. Table provides
LS means, time by treatment P-values, time P-values, and treatment P-
values, as well as means comparisons results for serum glucose, insulin,
acute phase protein, and cytokine response variables. (DOCX 26 kb)
Abbreviations
IL-1α: Interleukin-1-alpha; TNFα: Tumor necrosis factor-alpha; AA: Amino acid;
ADF: Acid detergent fiber; ADFI: Average daily feed intake; ADG: Average
daily gain; AHP: Activity heat production; APP: Acute phase protein;
ATTD: Apparent total tract digestibility; BW: Body weight; CBC: Complete
blood count; CON: Control treatment; CP: Crude protein; DE: Digestible
energy; DM: Dry matter; DMI: Dry matter intake; EE: Acid hydrolyzed ether
extract; ENZ: Enzyme treatment; FHP: Fasting heat production; FHPtotal: Total
fasting heat production; FIIR: Feed-induced immune response; GE: Gross
energy; GM-CSF: Granulocyte macrophage colony-stimulating factor; HI: Heat
increment; HP: Heat production; HP10: Heat production over 10 h post-
challenge; HPlow: Average of 10 lowest HP values over 10 h post-challenge;
HPtotal: Total heat production; IL: Interleukin; IL-1ra: Interleukin-1-receptor
antagonist; ISS: Immune system stimulation treatment; kmg: Energy efficiency
for maintenance and growth; LD: Lipid deposition; LPS: Lipopolysaccharide;
MBL: Mannose binding lectin; ME: Metabolizable energy; MEm: Metabolizable
energy used for maintenance; N: Nitrogen; NDF: Neutral detergent fiber;
NE: Net energy; NR: Nitrogen retention; PD: Protein deposition; RE: Retained
energy; REl: Retained energy as lipid; REp: Retained energy as protein;
RFI: Residual feed intake; RQ: Respiratory quotient; RQfast: Respiratory quotient
during the fasting period of heat production measurements;
RQfed: Respiratory quotient during the fed period of heat production
measurements; TEF: Thermic effect of feeding; VCO2: Volume of carbon
dioxide produced; VO2: Volume of oxygen consumed; WBC: White blood cell
Acknowledgments
The authors would like to thank Deepak Velayundhan and Atta Agyekum for
their technical assistance, Elanco® for financial support of this research, and
National Pork Board for financial support of Nichole Huntley’s graduate
program.
Funding
Financial support of NH graduate program provided by the National Pork
Board. Financial and in-kind support provided by Elanco, Greenfield, IN, USA.
Neither funding agency had a role in the design, analysis, or writing of this
article.
Availability of data and materials
All data generated or analyzed during this study are included in this
published article and its additional information files.
Authors’ contributions
NH and JP designed the study and had primary responsibility for the final
content of the manuscript; CMN provided essential equipment and materials;
NH conducted the research with the assistance of CMN graduate students;
and NH analyzed data and wrote the manuscript. All authors have read and
approved the final manuscript.
Ethics approval
All experimental procedures adhered to guidelines for the ethical and
humane use of animals for research and were reviewed and approved
by the University of Manitoba Animal Care Committee.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Animal Science, Iowa State University, Ames, IA 50011, USA.
2Department of Animal Science, University of Manitoba, 226 Animal Science
Building, Winnipeg, MB R3T 2N2, Canada.
Huntley et al. Journal of Animal Science and Biotechnology  (2018) 9:47 Page 14 of 16
Received: 7 December 2017 Accepted: 14 May 2018
References
1. Gabler N, Spurlock M. Integrating the immune system with the regulation
of growth and efficiency. J Anim Sci. 2008;86:E64–74.
2. Mani V, Weber TE, Baumgard LH, Gabler NK. Endotoxin, inflammation, and
intestinal function in livestock. J Anim Sci. 2012;90:1452–65.
3. Gazi U, Martinez-Pomares L. Influence of the mannose receptor in host
immune responses. Immunobiology. 2009;214:554–61.
4. Zhang L, Tizard IR. Activation of a mouse macrophage cell line by
acemannan: the major carbohydrate fraction from Aloe vera gel.
Immunopharmacology. 1996;35:119–28.
5. Duncan CJG, Pugh N, Pasco DS, Ross SA. Isolation of a galactomannan that
enhances macrophage activation from the edible fungus Morchella
esculenta. J Agric Food Chem. 2002;50:5683–5.
6. Anderson DM, Hsiao HY, Dale NM. Identification of an inflammatory
compound for chicks in soybean meal. Poult Sci. 2008;88:153.
7. Li Y, Chen X, Chen Y, Li Z, Cao Y. Effects of β-mannanase expressed by
Pichia pastoris in corn-soybean meal diets on broiler performance, nutrient
digestibility, energy utilization and immunoglobulin levels. Anim Feed Sci
Technol. 2010;159:59–67.
8. Rakhshandeh A, de Lange CFM. Evaluation of chronic immune system
stimulation models in growing pigs. Animal. 2012;6:305–10.
9. Wright KJ, Balaji R, Hill CM, Dritz SS, Knoppel EL, Minton JE. Integrated
adrenal, somatotropic, and immune responses of growing pigs to treatment
with lipopolysaccharide. J Anim Sci. 2000;78:1892–9.
10. Baracos VE, Whitmore WT, Gale R. The metabolic cast of fever. Can J Physiol
Pharmacol. 1987;65:1248–54.
11. Kvidera SK, Horst EA, Abuajamieh M, Mayorga EJ, Fernandez MVS, Baumgard
LH. Estimating glucose requirements of an activated immune system in
growing pigs. J Anim Sci. 2017;95:5020–9.
12. NRC. Nutrient requirements of swine. 11th revis. Washington, DC: National
Academy Press; 2012.
13. Gabler NK, Spencer JD, Webel DM, Spurlock ME. N-3 PUFA attenuate
lipopolysaccharide-induced down-regulation of toll-like receptor 4
expression in porcine adipose tissue but does not alter the expression of
other immune modulators. J Nutr Biochem. 2008;19:8–15.
14. Velayudhan DE, Heo JM, Nyachoti CM. Net energy content of dry extruded-
expelled soybean meal fed with or without enzyme supplementation to
growing pigs as determined by indirect calorimetry. J Anim Sci. 2015;93:
3402–9.
15. Ayoade DI, Kiarie E, Neto T, Nyachoti CM. Net energy of diets containing
wheat-corn distillers dried grains with soluble as determined by indirect
calorimetry, comparative slaughter, and chemical composition methods. J
Anim Sci. 2012;90:4373–9.
16. Aulick LH, Arnhold H, Hander EH, Mason AD. A new open and closed
respiration chamber. Q J Exp Physiol. 1983;68:351–7.
17. AOAC. In: Horwitz W, Latimer GW, editors. Official methods of analysis of
AOAC international. 18th ed. Association of Official Analytical Chemists
International: Gaithersburg; 2007.
18. Van Soest PJ, Robertson JB. Systems of analysis for evaluating fibrous feeds.
In: Pigden WJ, Balch CC, Graham M, editors. Work stand anal Methodol feed.
Ottawa: International Development Research Centre; 1979. p. 49–60.
19. Goering HK, Van Soest PJ. Forage fiber analyses (apparatus, reagents,
procedures, and some applications). Agric Handb. 1970:379:1–20.
20. Noblet J, van Milgen J. Energy value of pig feeds: effect of pig body weight
and energy evaluation system. J Anim Sci. 2004;82:E229–38.
21. Noblet J, Fortune H, Shi XS, Dubois S. Prediction of net energy value of
feeds for growing pigs. J Anim Sci. 1994;72:344–54.
22. Brouwer E. Report of the sub-committee on constants and factors. In:
Blaxter L, editor. Proc 3rd Symp energy Metab. London: Academic Press;
1965. p. 441–3.
23. Jørgensen H. Methane emission by growing pigs and adult sows as
influenced by fermentation. Livest Sci. 2007;109:216–9.
24. Noblet J, Karege C, Dubois S, Van Milgen J. Metabolic utilization of energy
and maintenance requirements in growing pigs: effects of sex and
genotype. J Anim Sci. 1999;77:1208–16.
25. Labussière E, van Milgen J, CFM d L, Noblet J. Maintenance energy
requirements of growing pigs and calves are influenced by feeding level. J
Nutr. 2011;141:1855–61.
26. Noblet J, Shi XS, Dubois S. Effect of body weight on net energy value of
feeds for growing pigs. J Anim Sci. 1994;72:648–57.
27. Krueger R, Derno M, Goers S, Metzler-Zebeli BU, Nuernberg G, Martens K,
et al. Higher body fatness in intrauterine growth retarded juvenile pigs is
associated with lower fat and higher carbohydrate oxidation during ad
libitum and restricted feeding. Eur J Nutr. 2014;53:583–97.
28. Derno M, Jentsch W, Schweigel M, Kuhla S, Metges CC, Matthes HD.
Measurements of heat production for estimation of maintenance energy
requirements of Hereford steers. J Anim Sci. 2005;83:2590–7.
29. Labussière E, Dubois S, van Milgen J, Noblet J. Partitioning of heat
production in growing pigs as a tool to improve the determination of
efficiency of energy utilization. Front Physiol. 2013;4:1–10.
30. Gerrits WJJ, Bosch MW, van den Borne JJGC. Quantifying resistant starch
using novel, in vivo methodology and the energetic utilization of
fermented starch in pigs. J Nutr. 2012;142:238–44.
31. Johnson RW. Inhibition of growth by pro-inflammatory cytokines: an
integrated view. J Anim Sci. 1997;75:1244–55.
32. Choct M, Dersjant-Li Y, McLeish J, Peisker M. Soy oligosaccharides and
soluble non-starch polysaccharides: a review of digestion, nutritive and anti-
nutritive effects in pigs and poultry. Asian-Australasian J Anim Sci. 2010;23:
1386–98.
33. Kraehenbuhl J-P, Corbett M. Keeping the gut microflora at bay. Science.
2004;303:1624–5.
34. Owusu-Asiedu A, Patience JF, Laarveld B, Van Kessel AG, Simmins PH, Zijlstra
RT. Effects of guar gum and cellulose on digesta passage rate, ileal
microbial populations, energy and protein digestibility, and performance of
grower pigs. J Anim Sci. 2006;84:843–52.
35. Adibmoradi M, Mehri M, Samie A, Shivazad M, Adibmoradi M, Samie A,
et al. Effects of β-mannanase on broiler performance, gut morphology and
immune system. Afr J Biotechnol. 2010;9:6221–8.
36. Kim JS, Ingale SL, Lee SH, Kim KH, Kim JS, Lee JH, et al. Effects of energy
levels of diet and β-mannanase supplementation on growth performance,
apparent total tract digestibility and blood metabolites in growing pigs.
Anim Feed Sci Technol. 2013;186:64–70.
37. Lv JN, Chen YQ, Guo XJ, Piao XS, Cao YH, Dong B. Effects of
supplementation of β-mannanase in corn-soybean meal diets on
performance and nutrient digestibility in growing pigs. Asian-Australasian. J
Anim Sci. 2013;26:579–87.
38. Yoon SY, Yang YX, Shinde PL, Choi JY, Kim JS, Kim YW, et al. Effects of
mannanase and distillers dried grain with solubles on growth performance,
nutrient digestibility, and carcass characteristics of grower-finisher pigs. J
Anim Sci. 2010;88:181–91.
39. Carr SN, Allee GL, Rincker PJ, Fry RS, Boler DD. Effects endo-1,4-β-D-
mannanase enzyme (Hemicell HT 1.5x) on the growth performance of
nursery pigs. Prof Anim Sci. 2014;30:393–9.
40. Pettey LA, Carter SD, Senne BW, Shriver JA. Effects of beta-mannanase
addition to corn-soybean meal diets on growth performance, carcass traits,
and nutrient digestibility of weanling and growing-finishing pigs. J Anim
Sci. 2002;80:1012–9.
41. Upadhaya SD, Park JW, Lee JH, Kim IH. Efficacy of β-mannanase
supplementation to corn-soya bean meal-based diets on growth
performance, nutrient digestibility, blood urea nitrogen, faecal coliform and
lactic acid bacteria and faecal noxious gas emission in growing pigs. Arch
Anim Nutr. 2016;70:33–43.
42. Jacela JY, Dritz SS, DeRouchey JM, Tokach MD, Goodband RD, Nelssen
JL. Effects of supplemental enzymes in diets containing distillers dried
grains with solubles on finishing pig growth performance. Prof Anim
Sci. 2010;26:412–24.
43. Di Paolo NC, Shayakhmetov DM. Interleukin 1α and the inflammatory
process. Nat Immunol. 2016;17:906–13.
44. Campos PHRF, Merlot E, Damon M, Noblet J, Le Floc’h N. High ambient
temperature alleviates the inflammatory response and growth
depression in pigs challenged with Escherichia coli lipopolysaccharide.
Vet J. 2014;200:404–9.
45. Buchanan JB, Johnson RW. Regulation of food intake by inflammatory
cytokines in the brain. Neuroendocrinology. 2007;86:183–90.
46. Campos PHRF, Labussière E, Dubois S, Renaudeau D, Noblet J. Effects of
ambient temperature on energy and nitrogen utilization in
lipopolysaccharide-challenged growing pigs. J Anim Sci. 2014;92:4909–20.
47. Rakhshandeh A, Htoo JK, de Lange CFM. Immune system stimulation of
growing pigs does not alter apparent ileal amino acid digestibility but
Huntley et al. Journal of Animal Science and Biotechnology  (2018) 9:47 Page 15 of 16
reduces the ratio between whole body nitrogen and sulfur retention.
Livest Sci. 2010;134:21–3.
48. Kluger MJ. The evolution and adaptive value of fever. Am Sci. 1978;66:38–43.
49. Owusu-Apenten R. Inflammation and innate immune response. Bioact
Pept Appl Improv Nutr heal. Boca Raton: Taylor and Francis Group;
2010. p. 181–238.
50. Le Floc’h N, Melchior D, Obled C. Modifications of protein and amino acid
metabolism during inflammation and immune system activation. Livest
Prod Sci. 2004;87:37–45.
51. Reeds PJ, Fjeld CR, Jahoor F. Do the differences between the amino acid
compositions of acute-phase and muscle proteins have a bearing on
nitrogen loss in traumatic stress? J Nutr. 1994;124:906–10.
52. Kluess J, Kahlert S, Panther P, Diesing A-K, Nossol C, Rothkötter H-J, et al.
Systemic E. Coli lipopolysaccharide but not deoxynivalenol results in
transient leukopenia and diminished metabolic activity of peripheral blood
mononuclear cells ex vivo. Mycotoxin Res. 2015;31:41–50.
53. Williams PN, Collier CT, Carroll JA, Welsh TH, Laurenz JC. Temporal pattern
and effect of sex on lipopolysaccharide-induced stress hormone and
cytokine response in pigs. Domest Anim Endocrinol. 2009;37:139–47.
54. Rakhshandeh A, Dekkers J, Kerr B, Weber T, English J, Gabler N. Effect of
immune system stimulation and divergent selection for residual feed intake
on digestive capacity of the small intestine in growing pigs. J Anim Sci.
2012;90:233–5.
55. Koopmans SJ, van der Staay FJ, le Floc’h N, Dekker R, van Diepen JTM,
Jansman AJM. Effects of surplus dietary L-tryptophan on stress,
immunology, behavior, and nitrogen retention in endotoxemic pigs. J Anim
Sci. 2012;90:241–51.
56. Wang M, Chen Y, Zhang Y, Zhang L, Lu X, Chen Z. Mannan-binding lectin
directly interacts with toll-like receptor 4 and suppresses lipopolysaccharide-
induced inflammatory cytokine secretion from THP-1 cells. Cell Mol
Immunol. 2011;8:265–75.
57. Wang M, Zhang Y, Chen Y, Zhang L, Lu X, Chen Z. Mannan-binding lectin
regulates dendritic cell maturation and cytokine production induced by
lipopolysaccharide. BMC Immunol. 2011;12:1–10.
58. Marinkovic S, Jahreis GP, Wong GG, Baumann H. IL-6 modulates the
synthesis of a specific set of acute phase plasma proteins in vivo. J
Immunol. 1989;142:808–12.
59. Le Floc’h N, Lebellego L, Matte JJ, Melchior D, Sève B. The effect of sanitary
status degradation and dietary tryptophan content on growth rate and
tryptophan metabolism in weaning pigs. J Anim Sci. 2009;87:1686–94.
60. Reeds P, Jahoor F. The amino acid requirements of disease. Clin Nutr. 2001;
20:15–22.
61. Weber TE, van Sambeek DM, Gabler NK, Moreland S, Johal S, Edmonds MS.
Effects of dietary humic and butyric acid on growth performance and
response to lipopolysaccharide in young pigs. J Anim Sci. 2014;92:4172–9.
62. Adewole DI, Kim IH, Nyachoti CM. Gut health of pigs: challenge models and
response criteria with a critical analysis of the effectiveness of selected feed
additives - a review. Asian-Australasian. J Anim Sci. 2016;29:909–24.
63. Demas GE, Chefer V, Talan MI, Nelson RJ. Metabolic costs of mounting an
antigen-stimulated immune response in adult and aged C57BL/6J mice. Am
J Physiol Integr comp. Physiol. 1997;273:R1631–7.
64. Jin MB, Shimahara Y, Yamaguchi T, Ichimiya M, Kinoshita K, Oka T, et al. The
effect of a bolus injection of TNF-alpha and IL-1 beta on hepatic energy
metabolism in rats. J Surg Res. 1995;58:509–15.
65. Tsigos C, Papanicolaou D, Defensor R, Mitsiadis C, Kyrou I, Chrousos G. Dose
effects of recombinant human interleukin-6 on pituitary hormone secretion
and energy expenditure. Neuroendocrinology. 1997;66:54–62.
66. Moon HK, Han IK, Gentry JL, Parmentier HK, Schrama JW. Effects of chronic
inflammation on energy metabolism and growth performance in weanling
pigs. Asian-Australasian. J Anim Sci. 1999;12:174–9.
67. Williams NH, Stahly TS, Zimmerman DR. Effect of chronic immune system
activation on the rate, efficiency, and composition of growth and lysine
needs of pigs fed from 6 to 27 kg. J Anim Sci. 1997;75:2463–71.
68. Labussière E, Dubois S, Gilbert H, Thibault JN, Le Floc’h N, Noblet J, et al.
Effect of inflammation stimulation on energy and nutrient utilization in
piglets selected for low and high residual feed intake. Animal. 2015;9(10):
1653–61.
69. Barnes DM, Song Z, Klasing KC, Bottje W. Protein metabolism during an
acute phase response in chickens. Amino Acids. 2002;22:15–26.
70. Shastak Y, Ader P, Feuerstein D, Ruehle R, Matuschek M. ß-Mannan and
mannanase in poultry nutrition. Worlds Poult Sci J. 2015;71:161–74.
Huntley et al. Journal of Animal Science and Biotechnology  (2018) 9:47 Page 16 of 16
